Weitong Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Weitong Lu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sirong Shi
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China
4 shared publications - Ruijianghan Shi
Department of Oral and Craniomaxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China
2 shared publications - Yang Chen
Department of Pediatric Surgery, Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China
2 shared publications - Yujie Zhu
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China
2 shared publications - Yunfeng Lin
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu Sichuan China
2 shared publications Dexuan Xiao
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China
1 shared publication
Latest Publications
- 10 September 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (34) , 18456-18467
Tetrahedral framework nucleic acids loaded with microRNA-17 for treating temporomandibular joint osteoarthritis: mechanisms of action
Schematic of TM17 : tFNAs assembled from four ssDNAs conjugated with sticky-end miR17 (cmiR17) enter IL-1β-induced inflamed chondrocytes, inhibit inflammation and restore cartilage matrix, enabling nucleic acid therapy for TMJOA.
- 10 September 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (34) , 18456-18467
Tetrahedral framework nucleic acids loaded with microRNA-17 for treating temporomandibular joint osteoarthritis: mechanisms of action
Schematic of TM17 : tFNAs assembled from four ssDNAs conjugated with sticky-end miR17 (cmiR17) enter IL-1β-induced inflamed chondrocytes, inhibit inflammation and restore cartilage matrix, enabling nucleic acid therapy for TMJOA.
- 24 October 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (46) , 21531-21544
A bioswitchable siRNA delivery system: RNAi therapy based on tetrahedral framework nucleic acids for bone defect repair
BiRDS successfully delivered CKIP-1 siRNA into BMSCs, targeting and silencing CKIP-1, which promoted the osteogenic differentiation of BMSCs and enhanced bone defect repair.
- 24 October 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (46) , 21531-21544
A bioswitchable siRNA delivery system: RNAi therapy based on tetrahedral framework nucleic acids for bone defect repair
BiRDS successfully delivered CKIP-1 siRNA into BMSCs, targeting and silencing CKIP-1, which promoted the osteogenic differentiation of BMSCs and enhanced bone defect repair.
- Open Access
- 29 August 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (38) , 27904-27927
Nanomaterials: innovative approaches for addressing key objectives in periodontitis treatment
Periodontitis is a chronic inflammatory disease primarily caused by dental plaque, which is a significant global public health concern due to its high prevalence and severe impact on oral, and even systemic diseases.
- 29 August 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (38) , 27904-27927
Open AccessNanomaterials: innovative approaches for addressing key objectives in periodontitis treatment
Periodontitis is a chronic inflammatory disease primarily caused by dental plaque, which is a significant global public health concern due to its high prevalence and severe impact on oral, and even systemic diseases.
- 10 February 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (15) , 7363-7377
Framework nucleic acids as promising reactive oxygen species scavengers for anti-inflammatory therapy
Framework nucleic acid nanomaterials possess excellent antioxidative and anti-inflammatory therapeutic properties through scavenging reactive oxygen species.
- 10 February 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (15) , 7363-7377
Framework nucleic acids as promising reactive oxygen species scavengers for anti-inflammatory therapy
Framework nucleic acid nanomaterials possess excellent antioxidative and anti-inflammatory therapeutic properties through scavenging reactive oxygen species.
- Open Access
- 29 August 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (37) , 26288-26301
Application and prospects of nucleic acid nanomaterials in tumor therapy
Cancer poses a great threat to human life, and current cancer treatments, such as radiotherapy, chemotherapy, and surgery, have significant side effects and limitations that hinder their application. Nucleic acid nanomaterials have specific spatial configurations and can be used as nanocarriers to deliver different therapeutic drugs, thereby enabling various biomedical applications, such as biosensors and cancer therapy. In recent decades, a variety of DNA nanostructures have been synthesized, and they have demonstrated remarkable potential in cancer therapy related applications, such as DNA origami structures, tetrahedral framework nucleic acids, and dynamic DNA nanostructures. Importantly, more attention is also being paid to RNA nanostructures, which play an important role in gene therapy. Therefore, this review introduces the developmental history of nucleic acid nanotechnology, summarizes the applications of DNA and RNA nanostructures for tumor treatment, and discusses the development opportunities for nucleic acid nanomaterials in the future.
- 29 August 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (37) , 26288-26301
Open AccessApplication and prospects of nucleic acid nanomaterials in tumor therapy
Cancer poses a great threat to human life, and current cancer treatments, such as radiotherapy, chemotherapy, and surgery, have significant side effects and limitations that hinder their application. Nucleic acid nanomaterials have specific spatial configurations and can be used as nanocarriers to deliver different therapeutic drugs, thereby enabling various biomedical applications, such as biosensors and cancer therapy. In recent decades, a variety of DNA nanostructures have been synthesized, and they have demonstrated remarkable potential in cancer therapy related applications, such as DNA origami structures, tetrahedral framework nucleic acids, and dynamic DNA nanostructures. Importantly, more attention is also being paid to RNA nanostructures, which play an important role in gene therapy. Therefore, this review introduces the developmental history of nucleic acid nanotechnology, summarizes the applications of DNA and RNA nanostructures for tumor treatment, and discusses the development opportunities for nucleic acid nanomaterials in the future.